Insiderhandel: Chief Operating Officer verkauft Aktien von Viking Therapeutics im Wert von 2.948.445$
Mancini, Marianna - Vorstand - Tag der Transaktion: 2023-03-28...…
32,605€
9,41%
Echtzeit-Aktienkurs Viking Therapeutics
Bid:
Ask:
Nachrichten zur Viking Therapeutics Aktie
Insiderhandel: Chief Operating Officer verkauft Aktien von Viking Therapeutics im Wert von 659.872$
Mancini, Marianna - Vorstand - Tag der Transaktion: 2023-03-29...…
Why Shares of Viking Therapeutics Skyrocketed This Week
The clinical-stage stock nearly doubled in price....…
Viking Therapeutics sheds on pricing $250M stock offering
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Viking Therapeutics Announces Pricing of $250 Million Public Offering of Common Stock
SAN DIEGO, March 29, 2023 /PRNewswire/ -- Viking Therapeutics, Inc. ("Viking") (Nasdaq: VKTX), a clinical-stage biopharmaceutical company focused on the…
Viking Therapeutics proposes stock offering, size not disclosed
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Viking Therapeutics Announces Proposed Public Offering of Common Stock
SAN DIEGO, March 29, 2023 /PRNewswire/ -- Viking Therapeutics, Inc. ("Viking") (Nasdaq: VKTX), a clinical-stage biopharmaceutical company focused on the…
Should You Buy Viking Therapeutics Stock After It Skyrocketed Over 60%?
Viking could have a strong rival to Novo Nordisks Wegovy and Ozempic and Lillys Mounjaro in the making....…
Viking Therapeutics Shares Soar on VK2735 Home-Run Data >VKTX
Viking Therapeutics Shares Soar on VK2735 Home-Run Data >VKTX...…
Pre-market Movers: Viking Therapeutics, Immuneering, Oscar Health, WiSA Technologies, Intra-Cellular Therapies
LONDON (dpa-AFX) - The following are some of the stocks making big moves in Tuesdays pre-market trading (as of 08.15…
Pre-market Movers: VKTX, IMRX, OSCR, WISA, ITCI.
LONDON (dpa-AFX) - The following are some of the stocks making big moves in Tuesdays pre-market trading (as of 08.15…
Viking’s stock rallies as it announces trial for oral version of obesity drug
Shares of Viking Therapeutics Inc. VKTX soared about 45% in premarket trading on Tuesday after the company said it started…
Form 8-K Viking Therapeutics, For: Mar 28
Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…
Viking Therapeutics Shares Surge Premarket on VK2735 Study Data >VKTX
Viking Therapeutics Shares Surge Premarket on VK2735 Study Data >VKTX...…
Viking Therapeutics to start obesity drug mid-stage trial
...(Reuters) - Viking Therapeutics Inc said on Tuesday it will begin......…
UPDATE 1-Viking Therapeutics to start obesity drug mid-stage trial
...(Adds trial details, shares )
March 28 (Reuters) - Viking......…
Is Viking Therapeutics a Smart Buy on the Dip?
The stock recently fell around 25% for reasons that had nothing to do with its lead program....…
Viking Therapeutics started at buy with $22 stock price target at Stifel Nicolaus
Um den gesamten Artikel unter marketwatch.com zu lesen, klicken Sie bitte auf die Überschrift...…
Viking Therapeutics to Present at SVB Securities Global Biopharma Conference
SAN DIEGO, Feb. 7, 2023 /PRNewswire/ -- Viking Therapeutics, Inc. ("Viking") (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the…
Viking Therapeutics Announces Completion of Enrollment in Phase 2b VOYAGE Study of VK2809 in Patients with Biopsy-Confirmed Non-Alcoholic Steatohepatitis (NASH)
Randomized, Double-Blind, Placebo-Controlled, Multicenter Study Evaluating Range of VK2809 Doses for up to 52 Weeks; Data for Primary Endpoint Expected…
Ascletis Believes that the Complaints Made by Viking Therapeutics Have No Merit and will Vigorously Defend Against such Complaints
HANGZHOU and SHAOXING, China, Jan. 2, 2023 /PRNewswire/ -- Ascletis Pharma Inc. (HKEX: 1672, "Ascletis") was recently informed that on…